Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AURKA | O14965 | 2/20 | 0.40 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.40 |
| ▸ | GRK6 | P43250 | 8/20 | 0.38 |
| ▸ | PAK1 | Q13153 | 1/20 | 0.38 |
| ▸ | IGF1R | P08069 | 7/20 | 0.36 |
| ▸ | FGFR1 | P11362 | 2/20 | 0.35 |
| ▸ | KDR | P35968 | 2/20 | 0.35 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.34 |
| ▸ | PIK3C3 | Q8NEB9 | 1/20 | 0.34 |
| ▸ | JAK3 | P52333 | 1/20 | 0.34 |
| ▸ | PLK4 | O00444 | 1/20 | 0.34 |
| ▸ | PAK4 | O96013 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3855238 | 0.95 | AURKA (0.42) | AURKAAURKBGRK6PAK1IGF1R | |
| SCHEMBL3852023 | 0.85 | GRK6 (0.42) | AURKAAURKBGRK6IGF1RFGFR1 | |
| SCHEMBL5822082 | 0.84 | GRK6 (0.42) | AURKAAURKBGRK6IGF1RFGFR1 | |
| SCHEMBL5770155 | 0.83 | IGF1R (0.49) | IGF1RPIK3C3 | |
| SCHEMBL5768922 | 0.79 | GRK6 (0.41) | AURKAGRK6IGF1RFGFR1KDR | |
| SCHEMBL5823577 | 0.79 | GRK6 (0.41) | AURKAAURKBGRK6IGF1RFGFR1 | |
| SCHEMBL3853457 | 0.77 | IGF1R (0.53) | PAK1IGF1RPIK3C3PAK4 | |
| SCHEMBL3849950 | 0.76 | GRK6 (0.42) | AURKAAURKBGRK6IGF1RNTRK1 | |
| SCHEMBL3852749 | 0.76 | GRK6 (0.41) | AURKAGRK6IGF1RFGFR1KDR | |
| SCHEMBL5819731 | 0.74 | IGF1R (0.48) | IGF1RNTRK1PIK3C3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1678169-A1 | 4-(PYRAZOL-3-YLAMINO)PYRIMIDINE DERIVATIVES FOR USE IN THE TREATMENT OF CANCER | Astrazeneca AB (SE) | 2006-07-12 | — | — | EP | disclosed |
| WO-2005040159-A1 | 4-(PYRAZOL-3-YLAMINO) PYRIMIDINE DERIVATIVES FOR USE IN THE TREATMENT OF CANCER | ASTRAZENECA AB (SE) | 2005-05-06 | — | — | WO | disclosed |